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ABSTRACT 
Ficus thonningii extract is known for its 
ethnobotanical uses in treatment of various 
infections, including those of the urinogenital 
tract. This study investigated the antimicrobial 
activity of extracts of F. thonningii on thirty four 
bacterial isolates from symptomatic urinary 
tract infections and four Candida isolates from 
vagina.  Qualitative phytochemical screening 
and successive gradient extraction of dried, 
pulverized leaves was carried out with hexane, 
ethyl acetate and methanol.  Bioactivity-guided 
fractionation of the ethyl acetate extract was 
done using vacuum liquid chromatography.  
Antibiotic susceptibility testing of bacterial 
isolates was determined using standard 
antibiotic discs.  Antimicrobial activity of the 
crude extracts and fractions was carried out on 
isolates using the agar well diffusion method.  
Minimum inhibitory concentrations (MIC) and 
minimum biocidal concentrations (MBC) were 
determined by agar-dilution and broth dilution 
respectively. Bactericidal kinetics of the ethyl 
acetate extracts of both plants was conducted 
using the viable count technique.  
Phytochemicals present include terpenoids, 
saponins, tannins and flavonoids.  The majority 
of clinical isolates were multi-drug resistant.  
The extracts and fractions of F. thonningii 
showed broad spectrum antimicrobial activity 
on susceptible as well as multi-antibiotic 
resistant isolates. The MIC ranged from 6.25 
mg/mL to 12.5 mg/mL while MBC was between 
6.25 mg/mL and > 50mg/mL.  The ethyl acetate 
extract showed potent bactericidal activity in a 
concentration-dependent manner on the 
microorganisms, with 100% microbicidal 
activity at 25 mg/mL within six hours for 
Staphyloccocus aureus and three hours for 
Candida albicans.  Leaf extracts of F. thonningii 
possess potent antimicrobial activity and may be 
useful in developing chemotherapeutic agents 
for the treatment of microbial infections. 
INTRODUCTION 
Plants and plant products, exemplified by 
ancient Chinese, African and Indian herbs, have 
been used in the treatment and management of 
infectious diseases since antiquity.  The 
effectiveness of plants in the treatment of infections 
can be inferred from the number of drugs derived 
from them (Gupta et al., 2012).  Although standard 
antibiotics are useful in treatment of infectious 
diseases, the continuing emergence of resistant 
organisms, undesired effects and exorbitant cost of 
drugs pose a significant challenge (Neuhauser et al., 
2003; Saga and Yamaguchi, 2009; Willey et al., 
2008).  Hence there is continued search for 
molecules with antimicrobial activity.   
Ficus thonningii (Blume) is a tree in the 
Moraceae family (Orwa et al., 2009).  F. thonningii 
is commonly referred to as common wild fig while 
the Yoruba tribe of Nigeria refers to it as ‘odan’ 
(Orwa et al., 2009), and used ethnobotanically in 
the treatment of urinary tract infections, veneral 
diseases, diarrhoea, dermatophyte infections 
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amongst others (Dangarembizi et al., 2013; 
Egharevba et al., 2015; Muthu et al., 2006; 
Nwachukwu et al., 2010; Orwa et al., 2009; 
Shanavaskhan et al., 2012; Teklehaymanot and 
Giday, 2007).  F. thonningii has been shown to be 
non-toxic to mammals at high doses in a number of 
in-vivo studies (Aniagu et al., 2008; Coker et al., 
2009); explaining why it has not been associated 
with toxicity in ethnomedicine.  Extracts of Ficus 
thonningii have been shown to be active against 
clinical bacteria isolated from various sources 
(Koné et al., 2004; Ndukwe et al., 2007; Usman et 
al., 2009) as well as fungi (Coker et al., 2016; 
Oyelana et al., 2011) and protozoa (Dangarembizi 
et al., 2014; Falade et al., 2014) but there is little 
information on its effect on pathogens of urinary 
tract and sexually transmitted infections for which 
it is used in local traditional medicine.  Hence, this 
study investigated the antimicrobial activity of F. 
thonningii extracts on pathogens isolated from 
vagina and symptomatic urinary tract infections.  
We hypothesized that extracts of F. thonningii is 
effective against selected isolates from urinary tract 
infections. 
MATERIALS AND METHODS 
Plant Collection. Leaves of F. thonningii were 
collected from Ojoo in Ibadan and authenticated at 
Forestry Research Institute of Nigeria (FRIN), 
Ibadan, Nigeria where a herbarium sample with 
voucher number FHI 1106898 was deposited. The 
leaves were then dried at room temperature (25 ± 3 
°C) and thereafter pulverized with an industrial 
grinder. 
Phytochemical Screening and Extraction of 
Metabolites. Qualitative phytochemical screening 
was conducted on the pulverized leaves following 
standard methods described by Vinoth et al., 
(2012).  
Test for tannins. Pulverized plant sample (0.5 g) 
was stirred with 10ml of distilled water in a test 
tube. This was filtered and a few drops of 0.1% 
ferric chloride were added. A brownish- green, 
blue-black or blue-green precipitate indicates a 
positive result.  
Test for saponins. Saponins were detected using 
the froth test in which 0.5 g of sample was weighed 
into a test tube containing 5 ml of distilled water. 
This was shaken and fitered. The filterate was 
shaken vigorously for a few minutes and observed 
for persistent frothing which is indicative of a 
positive result. To further confirm the presence of 
saponins, three drops of olive oil was added to tubes 
with persistent froth. The formation of emulsion 
confirms the presence of saponins. 
Test for terpenoids. Plant sample (0.5 g) was 
weighed into a clean test tube containing 2 ml of 
chloroform. This was then shaken and thereafter 
filtered after which concentrated H2SO4 was added 
to the filtrate. A reddish-brown color at the 
interphase indicates the presence of terpenoids. 
Test for alkaloids. Pulverized plant leaves (0.5 
g) were acidified with a mixture of 1% hydro 
chloric acid and ethanol for 2 minutes. This was 
shaken after which it was filtered through a filter 
paper. Ammonium hydroxide was added to the 
filtrate in a clean test tube after which chloroform 
was added. The chloroform layer was removed with 
the aid of a Pasteur pipette and then a few drops of 
Dragendorff’s reagent were added. The formation 
of orange brown precipitate indicates the presence 
of alkaloids. 
Test for cardiac glycosides. To detect cardiac 
glycosides, 0.5 g of sample was weighed into a 
clean test tube containing 5 ml of water. This was 
then filtered and 2 ml of glacial acetic acid 
containing a drop of ferric chloride was added to 
the filtrate after which concentrated hydrogen tetra 
oxo sulphate (VI) acid was added. A reddish-brown 
color at the interphase indicates the presence of 
cardiac glycosides. 
Test for steroids. Dried pulverized plant sample 
(0.5 g) was weighed into a clean test tube 
containing 2 ml of chloroform. This was then 
shaken and filtered. Acetic anhydride and 
concentrated hydrogen tetra oxo sulphate (VI) acid 
were then added. A positive test was indicated by a 
greenish color at the upper part of the liquid.  
Test for flavonoids. To query for flavonoids, 0.5 
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g of plant sample was weighed into a test tube 
containing 5 ml of distilled water. This was then 
filtered and dilute ammonia was added to the 
filtrate. A yellow color, persistent with the addition 
of concentrated hydrogen tetra oxo sulphate (VI) 
acid indicates a positive result  
Test for phenols. Ethyl acetate was used to 
extract 1g of plant sample. Extract was then filtered 
with Whatman filter paper. The development of 
blue black or brown coloration on the addition of 
ferric chloride reagent to the filtrate indicates the 
presence of phenol. 
Test for anthraquinones. Concentrated H2SO4 
was added to a clean test tube containing 0.5 g of 
plant sample. This was then filtered and chloroform 
was added to the filtrate. A color change upon the 
addition of ammonium hydroxide indicates a 
positive result. 
The dried, pulverized leaves of both plants were 
extracted successively with the soxhlet apparatus 
using n-hexane, ethyl acetate and methanol as 
solvents. The plant material was loaded into the 
thimble of the soxhlet which was then connected to 
a round bottom flask containing the desired solvent. 
The flask was mounted on a heating mantle while 
the condenser was fixed to the thimble for the 
purpose of condensing evaporated solvent. The 
condensed solvent drops into the thimble, soaks the 
plant sample and thus extracts the components of 
the plant. The extracts were then concentrated to 
dryness with the aid of a shaker water bath (Lab 
Tech shaker, model; LSI-3016R, Korea) set at 
60oC. The weight of the extracts was taken after 
which they were stored in the refrigerator at -200C. 
Microorganisms. Microbial strains of 
Escherichia coli (6), Pseudomonas aeruginosa (6), 
Klebsiella oxytoca (4), Klebsiella pneumoniae (4), 
Proteus vulgaris (3), Proteus mirabilis (3), 
Staphylococcus aureus (6) and Staphylococcus 
saprophyticus (2) were obtained from the 
Department of Medical Microbiology, University 
College Hospital, Ibadan, Nigeria and Lancet 
Laboratories, Ibadan. Control strains (Escherichia 
coli ATCC 35218, Pseudomonas aeruginosa 
ATCC 27853, and Staphylococcus aureus ATCC 
29213) were obtained from Molecular 
Microbiology Laboratory of the Department of 
Pharmaceutical Microbiology, University of 
Ibadan. Bacterial strains were isolated from patients 
with symptomatic urinary tract infections. The 
strains were identified with the Microbact and API 
systems by the respective clinical laboratories and 
their identities were confirmed using a panel of 
biochemical tests including; Gram stain, growth on 
appropriate selective media, oxidase test, catalase 
test, coagulase test, motility test, DNAse test, 
methyl red-voges proskauer test, citrate utilization, 
urease test, hydrogen sulfide production, 
fermentation of glucose, mannitol, maltose, lactose 
and sucrose. (Cheesbrough, 2006)  after which they 
were archived in agar slants at 40C. 
Antibiotic Susceptibility Testing. Antibiotic 
susceptibility testing was conducted on all bacterial 
isolates using the disc diffusion technique (CLSI 
2016). A panel of standard antibiotic discs which 
includes Ceftazidime 30 µg, Cefuroxime 30 µg, 
Gentamicin 10 µg, Ofloxacin 5 µg, Augmentin 30 
µg, Nitrofurantoin 300 µg, Ciproflxacin 5 µg, 
Cloramphenicol 30 µg, Augmentin 30 µg, 
Amoxycillin 25 µg, Erythromycin 5 µg, 
Tetracycline 10 µg, and Cloxacillin 5 µg were used 
for the screening. Isolate suspension equivalent to 
0.5 McFarland equivalence turbidity standard for 
each isolate was used to inoculate Mueller Hinton 
Agar plates with the aid of sterile cotton tipped 
applicators. Antibiotic discs were then aseptically 
placed on the surface of the agar after which plates 
were incubated at 37 0C for 24 hours. Zones of 
inhibition were recorded and the results were 
interpreted based on CLSI standards and analyzed 
with WHONET application. 
Antimicrobial Screening of Extracts. 
Antimicrobial screening of plant extracts was 
conducted using the agar well diffusion method. 
Mueller Hinton and Saboraud Dextrose Agar plates 
for bacteria and fungi respectively were inoculated 
with suspension of each isolate adjusted to 0.5 
McFarland Equivalent Turbidity Standard. 
Inoculum was evenly spread on the plates with the 
aid of sterile cotton tipped applicators. Equidistant 
wells were bored on seeded plates with the aid of 
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sterile 8 mm diameter cork borer and 0.2 mL of 
respective extract dilutions and controls were 
aseptically dispensed into corresponding wells and 
the plates were incubated at 37 0C for 24 hours for 
bacteria and 25 0C for 48 hours for fungi. 
Ciprofloxacin and fluconazole were used as the 
standard drug control for bacteria and fungi 
respectively, while methanol was used as negative 
control. Tests were performed in triplicates and 
mean diameter of zones of inhibition were recorded 
after period of incubation. 
Determination of Minimum Inhibitory 
Concentration of Extracts. Minimum inhibitory 
concentration (MIC) was determined using the agar 
dilution method (Klancnik et al., 2010; Wiegand et 
al., 2008). Different dilutions of extracts were made 
in Mueller Hinton Agar in petri dishes to final 
concentrations ranging from 0.39 mg/mL – 50 
mg/mL. An overnight broth culture of each isolate 
on Tryptone Soy Broth (TSB) was diluted and 
inoculated, with the aid of sterile swabs, in agar 
plates containing respective extract dilutions. Plates 
were incubated at 370C for 24 hours for bacteria and 
250C for 48 hours for fungi. The lowest 
concentration that prevented growth of isolates was 
recorded as the MIC.  
Determination of Minimum Biocidal 
Concentration of Extracts. The Minimum Biocidal 
Concentration (MBC) of the bioactive extracts was 
determined using concentrations equivalent to the 
MIC values, twice, four times and eight times the 
MIC values.  Overnight broth cultures of isolates 
were diluted and 0.5 mL of the 10-2 dilution was 
inoculated into 3.5 mL of sterile TSB. Thereafter, 1 
mL of each extract dilution which would yield the 
desired concentration was dispensed into 
appropriately labeled tubes. The tubes were then 
incubated at 370C for 24 hours and 250C for 48 
hours for bacteria and fungi respectively. Streaking 
on fresh Tryptone Soy Agar (TSA) plates was done 
from each tube after incubation and the lowest 
concentration showing no growth after appropriate 
period of incubation was recorded as the MBC. 
Time-Kill Assay. Bactericidal Kinetics was 
determined using the viable count technique. An 
overnight broth culture of each isolate in 5 ml of 
TSB was obtained. The isolates used were E. coli 
ATCC 35218, S. aureus ATCC 29213 and C. 
albicans. Broth cultures of actively growing cells 
were diluted and 0.1 ml of the 10-2 dilution was 
used to inoculate 3.9 ml TSB containing 1 ml of the 
extract at a final concentration equivalent to the 
MIC of each isolate. The resultant mixture, 
containing extract, culture and broth, was serially 
diluted and 100 µl appropriate dilutions were used 
to inoculate plates of TSA at different time intervals 
beginning at 0 minutes, 1 hour, 1 hour 30 minutes, 
2 hours, 3 hours, 4 hours, 5 hours, 6 hours and 24 
hours. The inoculum was evenly spread with the aid 
of a sterile glass spreader after which the plates 
were left for a few minutes to dry. The plates were 
then incubated at 37 0C for 24 hours and 250C for 
48 hours for bacteria and fungi respectively. The 
entire procedure was repeated for extract 
concentrations containing 2 times the MIC and 4 
times the MIC for each test isolate as well as 
controls without extract. After incubation period, 
the colony forming unit (CFU) was counted and a 
graph of the log of CFU per ml was plotted against 
time. 
Bioactivity Guided Fractionation. Vacuum 
liquid chromatography (VLC) was conducted for 
the ethyl acetate extract of Ficus thonningii. Fifteen 
grams of the crude extract was adsorbed with silica 
gel (60-200 mesh size) and VLC was conducted 
using 100 mL ratios hexane (Hex), hexane-ethyl 
acetate (Hex-EtOAc) mixtures, ethyl acetate-
methanol mixtures and methanol as eluents, all in 
increasing polarity. A thin layer chromatographic 
(TLC) plate was spotted with each fraction and this 
was chromatographed with a solvent mixture of 
ethyl acetate/methanol (9:1). Similar fractions on 
the basis of TLC profiles were pooled. 
The pooled fractions from VLC were 
concentrated to dryness after which their 
antimicrobial activity on selected clinical isolates 
was conducted using agar well diffusion method as 
described previously. 
RESULTS AND DISCUSSION 
The phytochemicals present in F. thonningi 
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include terpenoids, anthraquinones, saponins, 
tannins and alkaloids. Cardiac glycosides and 
steroids were absent (Figures 1 and 2) Clinical 
isolates used in this study were mostly multi-drug 
resistant. All Gram negative clinical bacteria used in 
this study were resistant to ampicillin and augmentin 
while Staphylococci were resistant to ceftazidime. 
The ethyl acetate extracts of F. thonningii produced 
larger zones of inhibition on clinical isolates than 
hexane and methanolic extracts as in Table 1. MIC 
and MBC values of ethyl acetate extract, as recorded 
in Table 2 are in the range of 6.25 mg/mL and ≥50 
mg/mL. Pooled fractions of ethyl acetate extracts 
produced appreciable zones of inhibition, greater 
than the crude extract (Table 3). The ethyl acetate 
extract inhibited the growth of E. coli ATCC 35218, 
S. aureus ATCC 29213 and C. albicans by 100% at 
1440 minutes, 390 minutes and 210 minutes 
respectively (Figures 3 – 5). 
Some of the phytochemicals present in F. 
thonningii, as captured above have been reported 
previously. Egharevba et al., (2015) reported the 
presence of saponins, tannins and flavonoids as well 
as absence of cardiac glycosides and steroids on F. 
thonningii. However, anthraquinones and alkaloids 
which were found in this work were absent in their 
study. Similarly, alkaloids and flavonoids as well as 
cardiac glycosides (which was absent in this study) 
were detected in F. thonningii (Oyelana et al., 2011). 
Also, the main groups of phytochemicals present in 
F. thonningii as reported by (Dangarembizi et al., 
2013) are alkaloids, terpenoids, flavonoids, tannins 
and essential oils. Worthy of note is the presence of 
anthraquinones observed in this study for F. 
thonningii as this was not reported in any literature 
encountered in the course of this work. The 
differences in phytochemicals detected in these 
studies could be as a result of difference in locations 
where the plants were collected as it has been shown 
that plant site affects it antimicrobial activity (Knief 
et al., 2010; Laforest-Lapointe et al., 2016). An array 
of phytochemicals isolated and identified from plants 
has been shown to confer varying degrees of 
antimicrobial properties to plants. It is believed that 
most plants produce such secondary metabolites in 
response to stress and invasion by microbes. 
Flavonoids for instance are very effective against a 
wide range of organisms (Tsuchiya et al., 1996) and 
they probably do this by forming complexes with 
bacterial cell walls as well as extracellular and 
soluble proteins. Terpenoids are bactericidal as they 
distort the structure and integrity of the microbial cell 
membrane, leading to cell lysis (Cowan, 1999). 
These and other phytochemicals present in the plant 
might have resulted in the medicinal property of the 
plant. Indeed, it has been proposed and elucidated 
that different phytochemicals act synergistically to 
produce the overall antimicrobial effect associated 
with medicinal plants (Padmanabhan and Jangle, 
2012). 
Clinical isolates showed a high rate of resistance 
to standard antibiotics. The majority of strains were 
Multi Drug-Resistant (MDR), Possible Extensively 
Drug-Resistant (PXDR) or Possible Pan Drug-
Resistant (PPDR) (CLSI, 2016; Magiorakos et al., 
2011). There was a high rate of resistance among the 
Pseudomonas aeruginosa isolates as all were 
classified as PXDR. All these correlated with the 
studies of (Neuhauser et al., 2003; Okon et al., 2014) 
which reported increasing resistance amongst P. 
aeruginosa and other Gram negative bacilli. The 
resistance profile of Proteus vulgaris was 
remarkable as the isolates were resistant to almost all 
the antibiotics employed. Only one isolate was 
sensitive to nitrofurantoin. It is important to state that 
the resistance recorded in this study cannot be 
extrapolated to the general population of organisms 
in the communities or areas where the isolates were 
collected as the number of each species of organisms 
used in this study is small, with the aim of merely 
testing the activity of the extracts on them. However, 
antibiotic susceptibility testing was necessary to 
know the susceptibility pattern of the isolates. 
The zones of inhibition shown by the hexane 
extract were small and as such it could be said that it 
had just minimal activity on test isolates or that the 
antimicrobial principles did not diffuse well. 
However the activity was consistent with 
concentration of the extract. The ethyl acetate extract 
was active against the isolates, producing 
appreciable zones of inhibition on both bacteria and 
fungi. Also, the ethyl acetate extract exhibited better 
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activity than hexane and methanol extracts, showing 
larger zones of inhibition. The methanol extract of F. 
thonningii was only moderately active against 
susceptible isolates showing lower zones of 
inhibition than the ethyl acetate extract but larger 
zones than the hexane. F. thonningii has been shown 
to be active against several bacterial pathogens 
(Usman et al., 2009; Koné et al., 2004; Ndukwe et 
al., 2007), similar to the observation in this study. 
The standard drug control (ciprofloxacin 10 
µg/mL) was active against only a few isolates. 
Although the activity of plant extracts, containing a 
lot of unknown and unstandardized substances, 
cannot be compared with standard drugs, the ethyl 
acetate extracts proved quite active. It produced 
appreciable zones of inhibition even on isolates that 
were resistant to the standard drug control and other 
drugs, including MDR, PXDR and PPDR bacteria. 
The activity of the plant extract on PPDR bacteria 
was observed keenly as this could be potentially 
useful in treating multi-drug resistant infections 
which continues to be a public health problem. This 
suggests that F thonningii may be possible leads in 
the development of potential antimicrobial agents 
against UTI infections.  
Minimum Inhibitory Concentrations of the 
extracts were quite high and this may be partly due 
to the fact that the extracts are crude, containing an 
array of unknown substances which made up the 
weight for concentrations, most of which may be 
inactive. Similarly, as expected based on the MIC 
values, the Minimum Biocidal Concentrations were 
high ranging from 6.25 mg/mL to above 50 mg/mL. 
MIC and MBC values for some isolates were the 
same; this suggests that the extract exerts its 
antimicrobial activity by killing rather than 
preventing the growth of susceptible bacteria. 
VLC fractionation was conducted for the most 
active extract which was that of ethyl acetate. 
Antimicrobial screening of VLC fractions against 
representative isolates was conducted after pooling 
of fractions based on TLC profiles. The results of 
antimicrobial screening against test isolates showed 
the most active fraction to be fraction 1. This 
indicates that the active compounds of the plant are 
probably non-polar in nature. Nevertheless, all 
fractions produced zones of inhibition indicating that 
there could be several compounds conferring 
antimicrobial activity to the plant. Zones produced 
by fractions were also larger than the crude, 
suggesting that further purification and isolation of 
active compounds would reduce the MICs and 
MBCs. 
The extract at 4MIC produced 100% inhibition of 
E. coli strain at 24 hours. At the 2MIC and 1MIC, 
growth was moderately reduced but at the time 24 
hours, there were still counts on plates. On S. aureus, 
the 4MIC and 2MIC resulted in 100% inhibition at 6 
hours 30 minutes and 24 hours respectively. As 
observed with E. coli, growth was reduced at 1MIC 
but death was not recorded at 24 hours. In essence 
the extract was more effective in killing the Gram 
positive organism (Staphylococcus aureus) 
employed in this study than the Gram negative 
(Escherichia coli) as shown by the time-kill curves. 
The extract at 4MIC and 2MIC led to death of C. 
albicans. However, at 1 MIC growth reduced a bit up 
until after four hours before increasing until the end 
of the experiment, suggesting that that concentration 
is not sufficient to kill the fungus. The presence of 
growth at concentrations where only reductions but 
not kill was observed after the duration of the study 
does not definitely mean that death would not be 
achieved at such concentrations, especially as 
reduction was evident. Instead, it could indicate that 
had the experiment be conducted for longer duration, 
death would possibly have been observed. 
This study has shown that F. thonningii is active 
on pathogens isolated from human urinary tract, thus 
corroborating its possible application in the 
treatment of urinogenital tract infections, treating 
even drug resistant infections if developed into 
standard drugs with further research. 
 




Figure 1: Percentage resistance of Gram negative isolates 
to select antibiotics. ‘Pae’ = Pseudomonas aeruginosa; 
‘Eco’ = Escherichia coli; ‘Kpn’ = Klebsiella 
pneumoniae; ‘Kox’ = Klebsiella oxytoca; ‘Pmi’ = 





Figure 2: Percentage resistance of Gram positive isolates 
to select antibiotics. ‘Sau’ = Staphylococcus aureus; 





Figure 3: Kill Kinetics of the Ethyl Acetate Extract of F. 







Figure 4: Kill Kinetics of the Ethyl Acetate Extract of F. 
thonningii on Staphylococcus aureus ATCC 29213  
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Figure 5: Kill Kinetics of the Ethyl Acetate Extract of 
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Table 1: Antimicrobial Screening of Crude Extracts on Clinical Isolates  























Isolate Zones of Inhibition (mm) 
P. aeruginosa 1 NZI NZI NZI 11.0 ± 0.8 14.0 ± 1.4 11.7 ± 0.5 12.3 ± 0.5 12.0 ± 0.0 11.3 ± 0.5 NZI NT 
P. aeruginosa 2 9.3 ± 0.5 NZI NZI 14.0 ± 0.8 12.7 ± 0.5 12.3 ± 0.5 16.3 ± 0.5 15.3 ± 0.5 12.0 ± 0.0 27.7.± 1.3 NT 
P. aeruginosa 3 12.3 ± 0.5 10.0 ± 0.0 NZI 18.3 ± 1.2 13.3 ± 0.5 11.0 ± 0.0 14.3 ± 0.5 13.0 ± 0.0 12.3 ± 1.2 NZI NT 
P. aeruginosa 4 10.7 ± 0.5 10.5 ± 0.5 10.7 ± 0.5 17.3 ± 0.5 14.3 ± 0.5 13.3 ± 0.5 14.7 ± 0.5 14.0 ± 0.8 12.0 ± 0.0 23.7 ± 1.3 NT 
P. aeruginosa 5 13.3 ± 0.5 12.3 ± 1.2 10.3 ± 0.5 18.0 ± 0.8 15.0 ± 0.0 13.7 ± 1.2 14.0 ± 0.0 12.0 ± 0.8 10.7 ± 0.5 30.3 ± 1.3 NT 
E. coli 1 NZI NZI NZI 13.0 ± 0.0 10.3 ± 0.5 9.3 ± 0.5 NZI NZI NZI 27.7 ± 0.9 NT 
E. coli 2 NZI NZI NZI 17.3 ± 0.9 12.3 ± 1.2 10.7 ± 0.5 12.3 ± 0.5 11.0 ± 0.8 10.3 ± 0.5 28.7 ± 1.3 NT 
E. coli 3 NZI NZI NZI 13.3 ± 0.5 11.0 ± 0.0 NZI 13.0 ± 0.8 NZI NZI 27.3 ± 0.5 NT 
E. coli 4 NZI NZI NZI 14.7 ± 0.9 12.3 ± 0.5 11.3 ± 0.5 12.0 ± 0.0 10.3 ± 0.5 10.0 ± 0.0 NZI NT 
E. coli 5 10.3 ± 1.2 NZI NZI 14.3 ± 0.5 11.3 ± 0.5 10.7 ± 0.5 10.7 ± 0.5 9.7 ± 0.5 11.3 ± 1.2 NZI NT 
K. pneumoniae 1 NZI NZI NZI 12.0 ± 0.8 9.0 ± 0.8 NZI NZI NZI NZI NZI NT 
K. pneumoniae 2 11.3 ± 0.5 NZI NZI 19.3 ± 1.2 12.3 ± 0.5 10.7 ± 0.5 12.3 ± 0.5 10.0 ± 0.0 9.5 ± 0.5 NZI NT 
K. pneumoniae 3 10.3 ± 1.2 11.3 ± 1.2 NZI 12.3 ± 0.5 10.3 ± 0.5 NZI NZI NZI NZI NZI NT 
K. pneumoniae 4 11.0 ± 0.8 9.0 ± 0.0 NZI 14.7 ± 0.9 NZI NZI NZI NZI NZI NZI NT 
K. oxytoca 1 NZI NZI NZI 16.0 ± 0.8 14.0 ± 0.0 12.3 ± 0.5 NZI NZI NZI NZI NT 
K. oxytoca 2 NZI NZI NZI NZI NZI NZI NZI NZI NZI NZI NT 
K. oxytoca 3 12.3 ± 1.2 10.3 ± 0.5 NZI 13.3 ± 0.5 10.3 ± 0.9 NZI 17.5 ± 0.5 12.7 ± 0.5 12.0 ± 0.0 20.7 ± 2.5 NT 
K. oxytoca 4 NZI NZI NZI NZI NZI NZI 17.0 ± 0.8 NZI NZI NZI NT 
P. mirabilis 1 14.3 ± 0.5 15.3 ± 0.5 13.7 ± 0.5 19.7 ± 0.9 18.3 ± 0.5 14.0 ± 0.0 NZI NZI NZI NZI NT 
P. mirabilis 2 NZI NZI NZI 16.0 ± 0.8 14.7 ± 0.5 12.3 ± 2.1 NZI NZI NZI 20.7 ± 0.9 NT 
P. mirabilis 3 10.0 ± 0.8 NZI NZI 15.7 ± 0.9 12.3 ± 0.5 11.7 ± 0.5 12.0 ± 0.0 10.7 ± 0.5 NZI NZI NT 
P. vulgaris 1 12.0 ± 0.8 14.7 ± 1.2 11.7 ± 1.2 22.0 ± 1.4 13.0 ± 0.8 11.0 ± 0.0 14.7 ± 0.9 12.3 ± 0.5 10.0 ± 0.0 NZI NT 
P. vulgaris 2 10.3 ± 0.5 10.0 ± 0.0 NZI 20.7 ± 1.7 13.3 ± 0.5 12.0 ± 0.0 19.3 ± 0.5 10.3 ± 0.5 NZI NZI NT 
P. vulgaris 3 12.0 ± 0.0 10.7 ± 1.7 NZI 15.3 ± 0.5 12.0 ± 0.0 11.0 ± 0.8 11.0 ± 0.8 10.3 ± 0.5 9.0 ± 0.0 NZI NT 
S. aureus 1 14.3 ± 0.5 NZI NZI 17.0 ± 1.4 13.0 ± 0.8 12.7 ± 0.5 12.3 ± 0.5 12.0 ± 0.0 9.3 ± 0.5 NZI NT 
S. aureus 2 11.7 ± 1.2 NZI NZI 22.0 ± 0.8 15.3 ± 1.2 12.7 ± 0.5 12.3 ± 0.5 10.3 ± 0.5 10.0 ± 0.0 21.0 ± 0.8 NT 
S. aureus 3 NZI NZI NZI 12.7 ± 1.2 14.3 ± 0.5 13.3 ± 0.5 14.0 ± 0.8 12.0 ± 0.0 10.7 ± 0.5 29.0 ± 0.8 NT 
S. aureus 4 15.7 ± 0.9 NZI NZI 17.3 ± 0.5 16.7 ± 0.5 12.0 ± 0.0 14.7 ± 1.2 11.7 ± 0.9 9.0 ± 0.0 NZI NT 
S. aureus 5 14.3 ± 2.1 NZI 10.0 ± 1.0 20.0 ± 0.0 15.0 ± 0.8 12.3 ± 0.5 12.0 ± 0.0 10.3 ± 0.5 NZI NZI NT 
S. saprophyticus 1 10.3 ± 0.5 NZI NZI 25.3 ± 0.5 18.3 ± 0.5 15.3 ± 0.5 14.3 ± 0.5 11.0 ± 0.0 NZI NZI NT 
S. saprophyticus 2 13.7 ± 0.9 NZI NZI 19.3 ± 0.5 15.0 ± 0.0 13.7 ± 0.5 12.0 ± 0.0 11.0 ± 0.0 10.7 ± 0.5 NZI NT 
C. albicans 1 10.3  ± 0.5 NZI NZI 15.0  ± 0.8 13.3  ± 0.5 10.0  ± 0.0 13.3  ± 0.5 9.3  ± 0.5 9.5  ± 0.5 NT NZI 
C. albicans 2 10.7  ± 0.5 10.0  ± 0.0 9.0  ± 0.0 15.7  ± 1.7 13.0  ± 0.0 11.3  ± 0.5 10.7  ± 0.5 9.3  ± 0.5 9.7  ± 0.5 NT NZI 
C. albicans 3 11.3  ± 0.5 10.3  ± 0.5 10.0  ± 0.0 16.3  ± 0.5 13.0  ± 0.8 12.7  ± 0.9 12.0  ± 0.0 11.7  ± 0.5 10.0  ± 0.8 NT NZI 
C. albicans 4 10.0  ± 0.8 9.0  ± 0.0 NZI 16.0  ± 0.8 13.7  ± 0.9 12.3  ± 0.5 10.0  ± 0.0 9.7  ± 0.5 9.0  ± 0.0 NT 14.7  ± 0.9 
Key: ‘E. coli’ = Escherichia coli; ‘P. aeruginosa’ = Pseudomonas aeruginosa; ‘K. pneumoniae’ = Klebsiella pneumonia; ‘K. oxytoca’ = Klebsiella oxytoca; ‘P. mirabilis’ = Proteus 
mirabilis; ‘P. vulgaris’ = Proteus vulgaris; ‘S. aureus’ = Staphylococcus aureus; ‘S. saprophyticus’ = Staphylococcus saprophyticus;‘NZI’ = no zone of inhibition ‘NT’ = not tested 
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Table 2: Minimum Inhibitory Concentration (MIC) and Minimum Biocidal Concentrations of the Ethyl Acetate Extracts 
Isolates 
Isolate MIC (mg/mL) MBC (mg/mL) 
P. aeruginosa ATCC 27853 12.5 12.5 
P. aeruginosa 1 6.25 12.5 
P. aeruginosa 2 12.5 25.0 
P. aeruginosa 3 12.5 12.5 
P. aeruginosa 4 12.5 25.0  
P. aeruginosa 5 12.5 25.0  
E. coli ATCC 35218 12.5 12.5  
E. coli 1 6.25 50.0  
E. coli 2 6.25 25.0  
E. coli 3 12.5  50.0  
E. coli 4 12.5  25.0  
E. coli 5 6.25  25.0  
K. pneumoniae 1 6.25  50.0  
K. pneumoniae 2 12.5  25.0  
K. pneumoniae 3 12.5  50.0  
K. pneumoniae 4 12.5  50.0  
K. oxytoca 1 12.5  25.0  
K. oxytoca 2 12.5  ≥50  
K. oxytoca 3 12.5  25.0  
K. oxytoca 4 12.5  ≥50  
P. mirabilis 1 12.5  12.5  
P. mirabilis 2 12.5  12.5  
P. mirabilis 3 6.25  12.5  
P. vulgaris 1 12.5 25.0  
P. vulgaris 2 12.5 25.0  
P. vulgaris 3 12.5 12.5  
S. aureus ATCC 29213 12.5 12.5   
S. aureus 1 12.5 12.5  
S. aureus 2 12.5 12.5 
S. aureus 3 12.5 12.5 
S. aureus 4 12.5 12.5 
S. aureus 5 12.5 25.0 
S. saprophyticus 1 6.25 12.5 
S. saprophyticus 2 12.5 12.5 
Key: ‘E. coli’ = Escherichia coli  ‘P. aeruginosa’ = Pseudomonas aeruginosa  
‘K. pneumoniae’ = Klebsiella pneumoniae ‘K. oxytoca’ = Klebsiella oxytoca   
‘P. mirabilis’ = Proteus mirabilis  ‘P. vulgaris’ = Proteus vulgaris 
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Table 3: Antimicrobial Screening of VLC pooled fractions of F. thonningii 
 Fraction 1 Fraction 2 Fraction 3 












Isolate Zones of Inhibition (mm) 
P. aeruginosa 2 31 15 18 14 14 11 
E. coli 2 21 15 12 11 10 NZI 
K. pneumoniae 1 24 10 13 10 10 9 
K. oxytoca 2 23 14 14 11 10 NZI 
S. aureus 2 30 22 15 14 12 NZI 
S. saprophyticus 2 29 27 18 12 15 13 
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